Kensey Nash Provides 4th Quarter Fiscal 2008 and Fiscal Year 200...( Ended...),Health

June 30, 2008 June 30, 2007

Range Range

Low High Low High

Loss Per Share - GAAP $(0.09) $(0.09) $(0.15)

Special Charges (a) 0.41 0.41 0.25

Adjusted Diluted Earnings

Per Share $0.32 $0.33 $0.11 191% 200%

(a) Loss per share for the fourth quarter of fiscal year 2008 is

estimated to include $5.1 million in after-tax charges, or $0.41 per

share, related to the sale of the Company's endovascular business.

Loss per share for the fourth quarter of fiscal year 2007 included an

after-tax charge for the discontinuance of the Company's embolic

protection platform of $3.1 million, or $0.25 per share.

Twelve Months Twelve Months Year over Year

Ended Ended % Change

June 30, 2008 June 30, 2007

Range Range

Low High Low High

Diluted Earnings Per

Share - GAAP $0.38 $0.39 $0.29 31% 34%

Special Charges (b) 0.58 0.58 0.25

Adjusted Diluted Earnings

Per Share $0.96 $0.97 $0.53 81% 83%

(b) Diluted earnings per share for fiscal year 2008 includes after-tax

charges of $2.0 million, or $0.16 per share, for the acceleration of

stock awards, approximately $214,000, or $0.02 per share, of charges

related to the discontinuation of the Company's embolic protection

platform, bot
'/>"/>